Marrero EJL, Leyva TM, Castellanos HJE

Language: Spanish
References: 11
Page: 78-84
PDF size: 125.04 Kb.

ABSTRACT

Introduction: urinary tract infections are a common problem in primary health care.
Objective: update the prevalence and susceptibility to available antibiotics in our environment.
Method: a retrospective study was carried out on the isolation of uropathogenic bacteria and antibiotic susceptibility of the most common organism in 2912 ambulatory patients with symptoms suggesting urinary tract infection. The sample was 484 patients with positive urine cultures and susceptibility study performed in Banes municipality, Holguin, from November 2012 to October 2013. Kirby and Bauer diffusion method was used.
Results: Escherichia coli were the most common pathogen, affecting females. This pathogen showed higher resistance to Ampicillin (83.7%), Cefazolin (74.5%), nalidixic acid (72.1%), Co-trimoxazole (57.3%), about (50.0%) of ciprofloxacin resistance, kanamycin and Ceftaxidima; and better sensitivity to gentamicin, cefotaxime, and ceftriaxone.
Conclusions: treatment options for first-line empiric treatment of urinary tract infections are gentamicin, cefotaxime, and ceftriaxone.

REFERENCES

1. Villaroel E, Navarro P, Ramos R. Escherichia coli identificadas en pacientes con infecciones urinarias: Sensibilidad antimicrobiana. Rev. Soc. Ven. Microbiol. Ene 2002 [citado 14 de Nov 2011];22(1):18-21. Disponible en: http://www.scielo.org.ve/scielo.php?script=sci_arttext&pid=S1315- 25562002000100005&lng=es&nrm=iso

2. National Committec for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: eleven informational supplement wayne; 2003: NCCLS document.

3. Lorente JA, Placer Santos J, Salvadó Costa M, Segura Álvarez YA, Gelabert M. Evolución de la resistencia antibiótica en las infecciones urinarias adquiridas en la comunidad. Rev Clin (Esp). 2005;(6):259-64.

4. Rempel OR, Laupland KB. Surveillance for antimicrobial resistant organisms: potential sources and magnitude of bias. Epidemiol Infect. 2009;137(12):1665-73.

5. Sánchez Merino JM, Maquieira Guillán C, Fuster Fox C, Medrano López R, González Pérez M, et al. Evolución de la resistencia a antibióticos de Escherichia coli en muestras de orina procedentes de la comunidad. Arch. Esp. urol. 2008;61(7):776-78.

6. Pasteran F, Méndez T, Rapoport M, Guerriero L, Corso A. Controlling false-positive results obtained with the Hodge and Masuda assays for detection of class a carbapcncmasc in species of Enterobacteriaceae by incorporating boronic acid. J Clin Microbiol. 2010;48(4):1323-32.

7. Rodríguez-Noriega E, Seas C, Guzmán-Bianco M, Mejía C, Álvarez C, Bavesteello L, et al. Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America. Int J Infect Dis. 2010;14(7):c560-6.

8. Casellas JM. Resistencia a los antibacterianos en América Latina: consecuencias para la infectología. Rev Panam Salud Pública. 2011;30(6):519-28.

9. Sánchez M, Sayalero M, Marinero M. Ciprofloxacina en las infecciones urinarias. 2008 [citado 21 Abr 2010]. Disponible en: http://www.intramed.net/contenidos.asp?contenidoID=58267

10. Pigrau C. Infecciones del tracto urinario nosocomiales. Rev Chil de Enfermedades Infecciosas y Microbiología. 2013;31(9):614-24.

11. Francisco Silva O, Marcela Cifuentes D, Eugenia Pinto C. Resultado de la vigilancia de susceptibilidad antimicrobiana en chile, Rev. Chil. Infect. 2011;28(1):19-27.